June 2018 FDA Recall Drug by Sca Pharmaceuticals
D-0918-2018 - Subpotent Drug
This Class II drug recall was voluntarily initiated by Sca Pharmaceuticals on June 29, 2018 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed in United States and the recall is currently terminated.
Recall Number: D-0918-2018
Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
06-29-2018
07-18-2018
3984 syringes
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
SCA Pharmaceuticals
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
United States
05-01-2019
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total Volume, Rx only , SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205 877-550-5059
Batch or Lot Expiration Information
Lot# : 20180507@21, Exp 7/1/2018; 20180511@9, 20180511@24, Exp 7/5/2018; 20180518@24, 20180518@31, 20180518@32, Exp 7/12/2018; 20180531@21, Exp 7/25/2018; 20180601@11, Exp 7/26/2018